Prawo i regulacje · 16/02/2021

PCI Synthesis Seeks Registration as Bulk Manufacturer of Controlled Substances

PCI Synthesis has submitted an application to the regulatory authorities to be registered as a bulk manufacturer of controlled substances, a key step in the production and distribution of certain medications. The application is part of the company's efforts to expand its pharmaceutical operations.